Radiation therapy company Mevion Medical Systems has received CE Mark approval for its Mevion S250 proton therapy system.
Mevion S250 is powered by the company's TriNiobium Core technology, a type of proton accelerator that reduces the cost, size, and complexity of proton therapy systems to levels similar to those of other types of advanced radiation therapy devices, according to the company.
The system is pending 510(k) clearance by the U.S. Food and Drug Administration (FDA).
Mevion, formerly known as Still River Systems, has established offices in the U.K. and Japan.
